IDDI Speaking at Cancer Precision Medicine Forum

December 2, 2019 — December 3, 2019

Berlin, Germany

IDDI Chairman at Cancer Precision Medicine Forum

Dr. Everardo Saad, Medical Director, IDDI will chair a Session at the Cancer Precision Medicine Forum on Innovations in Data Gathering & Effective Clinical Trial Design on December 3.

A greater understanding of disease and the realisation that cancer can no longer be defined in basic terms, is having a significant impact on clinical trials and drug development. Innovations in clinical trial design, and better understanding how to classify patients, including selection for novel cancer immunotherapies, has the potential to accelerate research and drug development so that the right therapies can rapidly be delivered to the right patients.

However, new approaches to clinical trials and the development of precision oncology require a change in the approach to research and data-gathering and its application to clinical practice. There is a growing need to analyse a broader range of clinical outcomes within research, treatment evaluation and reimbursement decisions. This session will explore the implications of re-thinking clinical trial design and some of the results already being achieved.

Join IDDI at this senior-level, focused event. Cancer Precision Medicine Forum is intended to bring together the most senior experts from across Europe and beyond, to provide a truly unique environment for sharing knowledge and enabling meaningful interactions with those at the very forefront of precision oncology.